Registration for the 4th STING & TLR-Targeted Therapies Summit 2023
is now closed.
Thank you to our Speakers, Sponsors & Delegates for joining us!
ADC & Engineered Antibodies
Maximizing the Therapeutic Window of ADCs & Engineered Antibodies
The World ADC Series covers the full breadth and depth of drug conjugates from next-generation conjugates and ADC target selection to ADC analytical development and manufacturing. Our mission is to provide the industry with knowledge and connections to maximize the therapeutic window of drug conjugates.
A manually curated database solution including clinical trials and drug records for preclinical, active, approved and discontinued drugs and treatments developed in partnership with the world's leading ADC drug developers and academics.
A vital year-round experience-sharing and problem-solving network to help drug developers make better ADC discovery decisions.
A trusted provider of market intelligence for anyone looking to understand the complexities of ADC and Engineered Antibodies research and development.